Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity.
about
Neurofilament in CSF-A biomarker of disease activity and long-term prognosis in multiple sclerosisNeurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS.Emerging Approaches for Validating and Managing Multiple Sclerosis Relapse.Serum neurofilament is associated with progression of brain atrophy and disability in early MS.Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy.Neurofilament light chain predicts disease activity in relapsing-remitting MS.The role of blood and CSF biomarkers in the evaluation of new treatments against multiple sclerosis.Fluid biomarker and electrophysiological outcome measures for progressive MS trials.Promise, Progress, and Pitfalls in the Search for Central Nervous System Biomarkers in Neuroimmunological Diseases: A Role for Cerebrospinal Fluid Immunophenotyping.Diagnostic methods used in searching for markers of atrophy in patients with multiple sclerosis.Towards a TDP-43-Based Biomarker for ALS and FTLD.'Progressive MS - macro views': The need for novel clinical trial paradigms to enable drug development for progressive MS.Science is 1% inspiration and 99% biomarkers.Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis.Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod.Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden.Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study
P2860
Q28276772-E6AD2ED9-F3AA-4A90-BCCC-927629D1920DQ37149094-B49CC62D-647F-48EC-9F58-66AD9EEF5BD1Q37729523-0A35CB3D-F70D-482E-8B9D-615BD1CF6185Q38381437-87AFEEF7-4794-4458-9C4E-68250A7A6EABQ38682945-EFF8D537-C87B-47F0-8D63-C37102EBCE48Q40262441-EFB90862-1CED-48E1-B8F8-0E6BAA0494C2Q47138197-12B62752-E1D3-45AD-AF64-106C4F5E861CQ47579410-9FCEDCEC-4B4B-4C24-B7DD-0B3287CC9583Q47638443-FED614E9-18E0-4A97-BEF8-90B531513249Q47657261-8E138BD0-B4FA-4330-91AC-CB280F435C2FQ49716124-C4342E69-FFB3-4B8F-ADB5-A22A189541BCQ49823859-67197FE7-051F-4C6F-AA37-D426F9BF3BB1Q50084570-3BD25DF0-A8ED-477D-B311-61B93AD21833Q50984144-2549FEB9-B10E-4BE6-9BAB-ADD4EB9B3C9DQ51110507-692EE129-E178-4694-9099-F1FC93CD11A4Q53212006-C1C29F20-D17A-49C2-B034-0A853D1DF672Q55247269-57571E69-C5E8-43D7-BE02-6ED7E7AA6A07Q57161829-EE338ABE-6502-44ED-A88A-9C8C4D7070CB
P2860
Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Serum neurofilament light chai ...... measures of disease severity.
@en
Serum neurofilament light chai ...... measures of disease severity.
@nl
type
label
Serum neurofilament light chai ...... measures of disease severity.
@en
Serum neurofilament light chai ...... measures of disease severity.
@nl
prefLabel
Serum neurofilament light chai ...... measures of disease severity.
@en
Serum neurofilament light chai ...... measures of disease severity.
@nl
P2093
P2860
P50
P356
P1476
Serum neurofilament light chai ...... I measures of disease severity
@en
P2093
Amandine Mathias
Axel Regeniter
Giulio Disanto
Guillaume Bonnier
Gunnar Krueger
Jens Kuhle
Mathieu Canales
Myriam Schluep
Tobias Derfuss
Özguer Yaldizli
P2860
P304
P356
10.1177/1352458515623365
P577
2016-01-11T00:00:00Z